Establish a pipeline of new adjuvant leads

Ended Definitive Contract Awarded Last action

Contract number
HHSN266200400043C
Awardee
Awarding agency
Obligated
$4,361,059

Award facts

Contract value 68% obligated
  • $4,399,904.21 Current, with exercised options
  • $6,386,213.21 Potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
Not on record
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers
Pricing
Cost Plus Fixed Fee
Place of performance
New Haven, CT 06511, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out 9 -$52,027
Other Administrative Action 8 · Change to art g.1. Project officer. $0
Funding Only Action 7 -$450,000
Funding Only Action 6 $1,041,076
Other Administrative Action 5 $0
Funding Only Action 4 $991,990
Funding Only Action 3 $945,233
Funding Only Action 2 $900,709
Funding Only Action 1 $36,000
Original award $948,078

Quick answers

Who was awarded contract HHSN266200400043C?

HHSN266200400043C was awarded to Vaxinnate Corporation by NIAID DEA OA Acquisitions (National Institutes of Health) on June 30, 2004.

How much is contract HHSN266200400043C worth?

The government has obligated $4,361,059 on HHSN266200400043C. Its current value, with exercised options, is $4,399,904. Its potential value, with all options, is $6,386,213.

Was contract HHSN266200400043C competed?

The extent of competition for HHSN266200400043C was full and open competition. The government received 4 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login